NIRS and multivariate methods for discrimination of morning glory species at different growth stages

Morning glory species are weeds very common in tropical crops, where they cause direct and indirect damage. The management of these species primarily relies on the application of herbicides, disregarding the growth stage and spatial distribution. Studies addressing new techniques for identifying these species may contribute to the development of proximal sensors for carrying out specific and rational management. Thus, the objective of this work was to use near infrared spectroscopy (NIRS) and multivariate analysis to discriminate two species of morning glory in three growth stages. NIRS spectra were collected from Ipomoea hederifolia and Merremia aegyptia were collected at three different stages in the spectral range of 4.000 to 10.000 cm-1. PCA and PC-LDA were used to analyze the entire spectrum and specific bands. NIRS associated with PCA and PC-LDA were sufficient to discriminate I. hederifolia and M. aegyptia species and their growth stages. PCA allowed a proper segregation of stages and species when applied individually PC-LDA correctly classified between 90.93 to 100% of species and stages. The best discrimination results were observed in the NIR spectra ranges from 4.500 to 6.000 cm-1 and 4.500 to 6.000 + 6.500 to 7.750 cm-1. This study represents an advance in the research and implementation of NIRS technology to discriminate weed species for the future development of equipment to assist in the adoption and/or performance of a specific management of weeds, capable of contributing to the reduction in the use of herbicides in crops

SOROPREVALÊNCIA PARA HIV E SÍFILIS EM CAMINHONEIROS QUE TRAFEGAM PELA BR153 NO CENTRO-OESTE BRASILEIRO

Introdução e objetivos: O longo período fora de casa favorece o comportamento de risco para DSTs, como aids e sífilis entre caminhoneiros. Sendo assim, o objetivo desse trabalho foi verificar a soroprevalência para HIV-1/2 e sífilis entre os caminhoneiros. Metodologia: Os caminhoneiros foram recrutados em um posto de combustível na BR-153, Km 15, Goiás, entre fev/2014 e fev/2015 (CEP #065/2013). Um questionário estruturado sobre os dados sócio demográficos foi realizado e foram colhidos 10 mL de sangue para realização da sorologia mediante ensaio imunoenzimatico para anti-HIV-1/2 (Interkit™) e para anti-Treponema pallidum (Tp) (Symbiosys™) e se positivos, realizados o sequenciamento do gene pol (protease e transcriptase reversa) para identificar mutações de resistência aos antirretrovirais (ARV) e os subtipos do HIV-1, e o VDRL, respectivamente. Resultados e discussões: Dos 666 caminhoneiros, 0,9 %(n=6) apresentaram sorologia positiva para HIV-1, sendo dois do subtipo C, uma BF e uma B, dessas, nenhuma apresentou resistência aos ARV e duas não amplificaram. 3/6 caminhoneiros HIV-1+ afirmaram relacionamento com parceiros ocasionais e 1/3 afirmou prática de sexo desprotegido. A soroprevalência para sífilis foi de 10,4% (69/666), 16/69 (23,2%) apresentaram VDLR positivo, 29/69 relataram ter relacionamento com parceiros ocasionais sendo que 10,1 % (n=7) afirmaram não usar preservativo. Entre os que passam de 15 a 30 dias fora de casa a soroprevalência para sífilis foi maior (p<0,05). Conclusão: O longo período fora de casa, que reflete a ausência familiar, foi um fator preponderante para maior prevalência da sífilis e a infecção pelo HIV-1 de diferentes subtipos demonstra que os caminhoneiros continuam dentro de uma rede de transmissibilidade contribuindo para a disseminação das DSTs em todo o país devido sua grande mobilidade geográfica

SOROPREVALÊNCIA PARA HEPATITES B E C EM CAMINHONEIROS QUE TRAFEGAM PELA BR153 PASSANDO PELO ESTADO DE GOIÁS NO CENTRO-OESTE BRASILEIRO

Introdução e objetivos: o hábito de vida dos caminhoneiros os condiciona a percorrer grandes distâncias e passar vários dias distante de sua companheira, o que predispõe a práticas sexuais eventuais, aumentando o risco para doenças sexualmente transmissíveis. O objetivo deste estudo foi verificar a soroprevalência de hepatites B e C entre os caminhoneiros. Metodologia: caminhoneiros foram recrutados em um posto de combustível (BR-153, Km 515) entre fev/2014 e fev/2015. Dados sócio-demográficos foram colhidos mediante questionário estruturado. Foram coletados 10mL de sangue e o soro foi aliquotado para a realização do enzimaimunoensaio anti-HBc total (WienerTM), HBsAg (WirnerTM) e anti-HCV (InterkitTM). Resultados e discussões: Um total de 666 caminhoneiros fez parte do estudo, sendo que 82 (12,3%) apresentaram sorologia positiva para anti-HBc e 5/82 (6,1%) para HBsAg. A mediana de idade dos caminhoneiros com sorologia positiva para hepatite B foi de 46,5 anos, 54,9% eram das regiões Sul/Sudeste e 40,2% passavam entre 15 e 30 dias longe de casa. 100% relataram ser heterossexuais, 55,2% eram casados, 42,7% (n=35) costumavam ter parceiros sexuais eventuais e 23,5% praticam sexo desprotegido, enquanto aqueles que possuem parceiras fixas (n=74), 63,5% alegam que nunca usam ou utilizam às vezes preservativos com suas parceiras. 13/82 alegam já ter recebido transfusão sanguínea, 5 (38,5%) antes de 1988. Houve um caso de hepatite C, em indivíduo do sexo feminino, 25 anos, casada, heterossexual, parceiro fixo e nunca recebeu transfusão sanguínea. Conclusões: a alta prevalência para hepatite B entre os caminhoneiros revela um grupo de comportamento de risco, sendo necessária a conscientização quanto a transmissibilidade das DSTs e a prática de sexo seguro

The Fourteenth Data Release of the Sloan Digital Sky Survey: First Spectroscopic Data from the extended Baryon Oscillation Spectroscopic Survey and from the second phase of the Apache Point Observatory Galactic Evolution Experiment

The fourth generation of the Sloan Digital Sky Survey (SDSS-IV) has been in operation since July 2014. This paper describes the second data release from this phase, and the fourteenth from SDSS overall (making this, Data Release Fourteen or DR14). This release makes public data taken by SDSS-IV in its first two years of operation (July 2014-2016). Like all previous SDSS releases, DR14 is cumulative, including the most recent reductions and calibrations of all data taken by SDSS since the first phase began operations in 2000. New in DR14 is the first public release of data from the extended Baryon Oscillation Spectroscopic Survey (eBOSS); the first data from the second phase of the Apache Point Observatory (APO) Galactic Evolution Experiment (APOGEE-2), including stellar parameter estimates from an innovative data driven machine learning algorithm known as "The Cannon"; and almost twice as many data cubes from the Mapping Nearby Galaxies at APO (MaNGA) survey as were in the previous release (N = 2812 in total). This paper describes the location and format of the publicly available data from SDSS-IV surveys. We provide references to the important technical papers describing how these data have been taken (both targeting and observation details) and processed for scientific use. The SDSS website (www.sdss.org) has been updated for this release, and provides links to data downloads, as well as tutorials and examples of data use. SDSS-IV is planning to continue to collect astronomical data until 2020, and will be followed by SDSS-V.Comment: SDSS-IV collaboration alphabetical author data release paper. DR14 happened on 31st July 2017. 19 pages, 5 figures. Accepted by ApJS on 28th Nov 2017 (this is the "post-print" and "post-proofs" version; minor corrections only from v1, and most of errors found in proofs corrected

Effect of crossover from placebo to darolutamide on overall survival in men with non-metastatic prostate cancer : sensitivity analyses from the randomised phase 3 ARAMIS study

Background: In the phase 3 ARAMIS study (NCT02200614), darolutamide significantly improved metastasis-free survival in patients with non-metastatic castration-resistant prostate cancer (nmCRPC). Following the primary analysis, the study was unblinded, and placebo recipients were permitted to cross over to open-label darolutamide. Despite crossover, darolutamide significantly improved overall survival (OS). We conducted sensitivity analyses to estimate the effect of placebo–darolutamide crossover on OS. Methods: Patients with nmCRPC were randomised to oral darolutamide 600 mg twice daily (n = 955) or placebo (n = 554). Prespecified (rank-preserving structural failure time [RPSFT] and iterative parameter estimation [IPE]) and post hoc (OS-adjusted censoring and inverse probability of censoring weighting [IPCW], with weightings for baseline testosterone and prostate-specific antigen) sensitivity analyses were conducted. Results: After unblinding, 170 of 554 placebo recipients (30.7%) crossed over to darolutamide. At the final OS intention-to-treat analysis (median 11.2 months after unblinding), darolutamide significantly improved OS by 31% versus placebo (hazard ratio [HR] 0.69, 95% confidence interval [CI] 0.53–0.88; P = 0.003). The benefit increased in the analyses adjusting for crossover is as follows: RPSFT HR 0.68, 95% CI 0.51–0.90; P = 0.007; IPE HR 0.66, 95% CI 0.51–0.84; P < 0.001; OS-adjusted censoring HR 0.59, 95% CI 0.45–0.76; IPCW HR 0.63, 95% CI 0.48–0.81. The favourable safety profile of darolutamide was maintained, including in crossover patients. Conclusions: After adjusting for crossover, darolutamide reduced the risk of death by up to 41% in patients with nmCRPC. The effect of darolutamide on OS may have been underestimated in the original intention-to-treat analysis.Peer reviewe

A Semantic Web Management Model for Integrative Biomedical Informatics

Data, data everywhere. The diversity and magnitude of the data generated in the Life Sciences defies automated articulation among complementary efforts. The additional need in this field for managing property and access permissions compounds the difficulty very significantly. This is particularly the case when the integration involves multiple domains and disciplines, even more so when it includes clinical and high throughput molecular data.The emergence of Semantic Web technologies brings the promise of meaningful interoperation between data and analysis resources. In this report we identify a core model for biomedical Knowledge Engineering applications and demonstrate how this new technology can be used to weave a management model where multiple intertwined data structures can be hosted and managed by multiple authorities in a distributed management infrastructure. Specifically, the demonstration is performed by linking data sources associated with the Lung Cancer SPORE awarded to The University of Texas MD Anderson Cancer Center at Houston and the Southwestern Medical Center at Dallas. A software prototype, available with open source at www.s3db.org, was developed and its proposed design has been made publicly available as an open source instrument for shared, distributed data management.The Semantic Web technologies have the potential to addresses the need for distributed and evolvable representations that are critical for systems Biology and translational biomedical research. As this technology is incorporated into application development we can expect that both general purpose productivity software and domain specific software installed on our personal computers will become increasingly integrated with the relevant remote resources. In this scenario, the acquisition of a new dataset should automatically trigger the delegation of its analysis

Balancing the immune response in the brain: IL-10 and its regulation

Background: The inflammatory response is critical to fight insults, such as pathogen invasion or tissue damage, but if not resolved often becomes detrimental to the host. A growing body of evidence places non-resolved inflammation at the core of various pathologies, from cancer to neurodegenerative diseases. It is therefore not surprising that the immune system has evolved several regulatory mechanisms to achieve maximum protection in the absence of pathology. Main body: The production of the anti-inflammatory cytokine interleukin (IL)-10 is one of the most important mechanisms evolved by many immune cells to counteract damage driven by excessive inflammation. Innate immune cells of the central nervous system, notably microglia, are no exception and produce IL-10 downstream of pattern recognition receptors activation. However, whereas the molecular mechanisms regulating IL-10 expression by innate and acquired immune cells of the periphery have been extensively addressed, our knowledge on the modulation of IL-10 expression by central nervous cells is much scattered. This review addresses the current understanding on the molecular mechanisms regulating IL-10 expression by innate immune cells of the brain and the implications of IL-10 modulation in neurodegenerative disorders. Conclusion: The regulation of IL-10 production by central nervous cells remains a challenging field. Answering the many remaining outstanding questions will contribute to the design of targeted approaches aiming at controlling deleterious inflammation in the brain.We acknowledge the Portuguese Foundation for Science and Technology (FCT) for providing a PhD grant to DLS (SFRH/BD/88081/2012) and a post-doctoral fellowship to SR (SFRH/BPD/72710/2010). DS, AGC and SR were funded by FEDER through the Competitiveness Factors Operational Programme (COMPETE) and National Funds through FCT under the scope of the project POCI-01-0145-FEDER007038; and by the project NORTE-01-0145-FEDER-000013, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). The MS lab was financed by Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE 2020—Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT in the framework of the project “Institute for Research and Innovation in Health Sciences ” (POCI-01-0145-FEDER-007274). MS is a FCT Associate Investigator. The funding body had no role in the design of the study and collection, analysis, and interpretation of the data and in writing the manuscript

Sloan Digital Sky Survey IV: Mapping the Milky Way, Nearby Galaxies, and the Distant Universe

We describe the Sloan Digital Sky Survey IV (SDSS-IV), a project encompassing three major spectroscopic programs. The Apache Point Observatory Galactic Evolution Experiment 2 (APOGEE-2) is observing hundreds of thousands of Milky Way stars at high resolution and high signal-to-noise ratios in the near-infrared. The Mapping Nearby Galaxies at Apache Point Observatory (MaNGA) survey is obtaining spatially resolved spectroscopy for thousands of nearby galaxies (median $z\sim 0.03$). The extended Baryon Oscillation Spectroscopic Survey (eBOSS) is mapping the galaxy, quasar, and neutral gas distributions between $z\sim 0.6$ and 3.5 to constrain cosmology using baryon acoustic oscillations, redshift space distortions, and the shape of the power spectrum. Within eBOSS, we are conducting two major subprograms: the SPectroscopic IDentification of eROSITA Sources (SPIDERS), investigating X-ray AGNs and galaxies in X-ray clusters, and the Time Domain Spectroscopic Survey (TDSS), obtaining spectra of variable sources. All programs use the 2.5 m Sloan Foundation Telescope at the Apache Point Observatory; observations there began in Summer 2014. APOGEE-2 also operates a second near-infrared spectrograph at the 2.5 m du Pont Telescope at Las Campanas Observatory, with observations beginning in early 2017. Observations at both facilities are scheduled to continue through 2020. In keeping with previous SDSS policy, SDSS-IV provides regularly scheduled public data releases; the first one, Data Release 13, was made available in 2016 July

The 13th Data Release of the Sloan Digital Sky Survey: First Spectroscopic Data from the SDSS-IV Survey Mapping Nearby Galaxies at Apache Point Observatory

The fourth generation of the Sloan Digital Sky Survey (SDSS-IV) began observations in July 2014. It pursues three core programs: APOGEE-2,MaNGA, and eBOSS. In addition, eBOSS contains two major subprograms: TDSS and SPIDERS. This paper describes the first data release from SDSS-IV, Data Release 13 (DR13), which contains new data, reanalysis of existing data sets and, like all SDSS data releases, is inclusive of previously released data. DR13 makes publicly available 1390 spatially resolved integral field unit observations of nearby galaxies from MaNGA,the first data released from this survey. It includes new observations from eBOSS, completing SEQUELS. In addition to targeting galaxies and quasars, SEQUELS also targeted variability-selected objects from TDSS and X-ray selected objects from SPIDERS. DR13 includes new reductions ofthe SDSS-III BOSS data, improving the spectrophotometric calibration and redshift classification. DR13 releases new reductions of the APOGEE-1data from SDSS-III, with abundances of elements not previously included and improved stellar parameters for dwarf stars and cooler stars. For the SDSS imaging data, DR13 provides new, more robust and precise photometric calibrations. Several value-added catalogs are being released in tandem with DR13, in particular target catalogs relevant for eBOSS, TDSS, and SPIDERS, and an updated red-clump catalog for APOGEE.This paper describes the location and format of the data now publicly available, as well as providing references to the important technical papers that describe the targeting, observing, and data reduction. The SDSS website, http://www.sdss.org, provides links to the data, tutorials and examples of data access, and extensive documentation of the reduction and analysis procedures. DR13 is the first of a scheduled set that will contain new data and analyses from the planned ~6-year operations of SDSS-IV.PostprintPeer reviewe

Sloan Digital Sky Survey IV: mapping the Milky Way, nearby galaxies, and the distant universe

We describe the Sloan Digital Sky Survey IV (SDSS-IV), a project encompassing three major spectroscopic programs. The Apache Point Observatory Galactic Evolution Experiment 2 (APOGEE-2) is observing hundreds of thousands of Milky Way stars at high resolution and high signal-to-noise ratios in the near-infrared. The Mapping Nearby Galaxies at Apache Point Observatory (MaNGA) survey is obtaining spatially resolved spectroscopy for thousands of nearby galaxies (median ). The extended Baryon Oscillation Spectroscopic Survey (eBOSS) is mapping the galaxy, quasar, and neutral gas distributions between and 3.5 to constrain cosmology using baryon acoustic oscillations, redshift space distortions, and the shape of the power spectrum. Within eBOSS, we are conducting two major subprograms: the SPectroscopic IDentification of eROSITA Sources (SPIDERS), investigating X-ray AGNs and galaxies in X-ray clusters, and the Time Domain Spectroscopic Survey (TDSS), obtaining spectra of variable sources. All programs use the 2.5 m Sloan Foundation Telescope at the Apache Point Observatory; observations there began in Summer 2014. APOGEE-2 also operates a second near-infrared spectrograph at the 2.5 m du Pont Telescope at Las Campanas Observatory, with observations beginning in early 2017. Observations at both facilities are scheduled to continue through 2020. In keeping with previous SDSS policy, SDSS-IV provides regularly scheduled public data releases; the first one, Data Release 13, was made available in 2016 July